Johnson & Johnson (BSP:JNJB34) Short-Term Debt : R$36,502 Mil (As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Johnson & Johnson Short-Term Debt?

Johnson & Johnson's Short-Term Debt for the quarter that ended in Dec. 2024 was R$36,502 Mil.

Johnson & Johnson's quarterly Short-Term Debt declined from Jun. 2024 (R$53,080 Mil) to Sep. 2024 (R$24,710 Mil) but then increased from Sep. 2024 (R$24,710 Mil) to Dec. 2024 (R$36,502 Mil).

Johnson & Johnson's annual Short-Term Debt declined from Dec. 2022 (R$66,910 Mil) to Dec. 2023 (R$16,909 Mil) but then increased from Dec. 2023 (R$16,909 Mil) to Dec. 2024 (R$36,502 Mil).

Johnson & Johnson Short-Term Debt Historical Data

The historical data trend for Johnson & Johnson's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Short-Term Debt Chart

Johnson & Johnson Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

13,535.71

21,296.35

66,910.32

16,909.21

36,502.28

Johnson & Johnson Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															16,909.21	42,577.29	53,080.02	24,709.66	36,502.28

Johnson & Johnson Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Johnson & Johnson Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Johnson & Johnson Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (BSP:JNJB34) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

JNJ:USA JNJ:Peru JNJ:Mexico JNJ_KZ:Kazakhstan 1JNJ:Italy JNJd:UK 0R34:UK JNJ0:Germany JNJ:Germany JNJ:Germany JNJ:Germany JNJ:Germany JNJ:Canada JNJ:Bulgaria JNJ:Austria JNJ:Argentina

Address

One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933

Website

https://www.jnj.com

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson Headlines

No Headlines